MARINUS PHARMACEUTICALS, INC.
RADNOR, PA 19087-5279
Visibility Score
43
Capabilities Narrative
Marinus is dedicated to improving treatment outcomes for patients with rare epilepsies and seizure disorders. Our lead drug candidate is designed to exhibit anti-epileptic activity by virtue of its GABAA receptor modulating properties and is being developed in intravenous (IV) and oral formulations ...
NAICS Codes
| Code | Description | Primary |
|---|---|---|
| 325412 | Pharmaceutical Preparation Manufacturing |
Keywords
Pharmaceutical development, epilepsy, acute care, medical countermeasures, nerve gas toxicity, status epilepticus, anti-convulsant therapy, intellectual property, orphan disease, pediatric indications, pediatric formulations, rare neurological conditions, intravenous therapeutics, oral therapeutics, suspension therapeutics
Contact Information
Business Details
- UEI
- MS6UM2NBDW91
- CAGE Code
- 4BX80
- Year Established
- 2003
- Legal Structure
- Corporation
- Congressional District
- 05